ArticleJournal of clinical medicine2022

Efficacy of Lenvatinib and Sorafenib in the Real-World First-Line Treatment of Advanced-Stage Hepatocellular Carcinoma in a Taiwanese Population.

Shou-Wu Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.